[go: up one dir, main page]

JP2003149136A - Optical image measurement method - Google Patents

Optical image measurement method

Info

Publication number
JP2003149136A
JP2003149136A JP2001347619A JP2001347619A JP2003149136A JP 2003149136 A JP2003149136 A JP 2003149136A JP 2001347619 A JP2001347619 A JP 2001347619A JP 2001347619 A JP2001347619 A JP 2001347619A JP 2003149136 A JP2003149136 A JP 2003149136A
Authority
JP
Japan
Prior art keywords
living body
concentration
component
optical image
measurement
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2001347619A
Other languages
Japanese (ja)
Inventor
Manami Kobayashi
まなみ 小林
Yasunobu Ito
康展 伊藤
Hisafumi Sakauchi
尚史 坂内
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shimadzu Corp
Original Assignee
Shimadzu Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shimadzu Corp filed Critical Shimadzu Corp
Priority to JP2001347619A priority Critical patent/JP2003149136A/en
Publication of JP2003149136A publication Critical patent/JP2003149136A/en
Withdrawn legal-status Critical Current

Links

Landscapes

  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)

Abstract

(57)【要約】 【課題】 被検体の成分濃度と測定データとの間の非直
線性を考慮して、より正確な成分濃度を求める。 【解決手段】 生体に光を照射し、生体から反射される
光を二次元検出器を用いて画像を得る光画像計測方法で
あり、生体中の組織情報と測定データとの間の非線形関
係を予め求めておき、この非線形関係を用いて生体中の
組織情報を求める。これによって、生体中の組織情報と
測定データとの間の非線形関係を考慮し生体中の組織情
報を求めることができる。
(57) [Summary] To obtain a more accurate component concentration in consideration of the non-linearity between the component concentration of a subject and measurement data. An optical image measurement method for irradiating a living body with light and obtaining an image of light reflected from the living body using a two-dimensional detector, wherein a non-linear relationship between tissue information in the living body and measurement data is obtained. It is obtained in advance, and tissue information in the living body is obtained using this nonlinear relationship. Thus, tissue information in the living body can be obtained in consideration of the nonlinear relationship between the tissue information in the living body and the measurement data.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【発明の属する技術分野】本発明は、生体組織の酸素化
ヘモグロビン、脱酸素化ヘモグロビン、メラニンの分布
を計測する光画像計測方法に関し、これらを二次元画像
に表示して組織や血流の正常、異常を診断する生体画像
診断に適用することができる。
TECHNICAL FIELD The present invention relates to an optical image measuring method for measuring the distribution of oxygenated hemoglobin, deoxygenated hemoglobin, and melanin in living tissue, which is displayed on a two-dimensional image to indicate normal tissue or blood flow. It can be applied to biological image diagnosis for diagnosing abnormalities.

【0002】[0002]

【従来の技術】生体等の被検体に光を照射し、被検体に
よって散乱、反射、吸収された光を受光し、被検体の組
織を光学的に計測する光学的計測方法が知られている。
このような光学的計測方法として、被検体からの反射光
や透過光を二次元検出器で検出して二次元画像を得る方
法や、光源から異なる距離に配置した複数の検出器を用
いて絶対量を得る方法等が提案されている。
2. Description of the Related Art An optical measuring method is known in which a subject such as a living body is irradiated with light and the light scattered, reflected and absorbed by the subject is received to optically measure the tissue of the subject. .
As such an optical measurement method, a method of obtaining a two-dimensional image by detecting reflected light or transmitted light from the subject with a two-dimensional detector, or using a plurality of detectors arranged at different distances from the light source A method for obtaining a quantity has been proposed.

【0003】しかしながら、二次元検出器を用いて二次
元画像を得る方法では、測定値が相対値であって絶対量
が得られないという問題があり、また、前記の絶対量の
測定方法を用いて二次元情報を得るには、装置構成や演
算処理が複雑であるという問題の他に、被検体の組織の
組成が均一であると仮定しているため、組成が不均一な
場合には、測定値が有意なものとは言えず正確な診断に
支障が生じるという問題がある。
However, the method of obtaining a two-dimensional image using a two-dimensional detector has a problem that the measured value is a relative value and an absolute amount cannot be obtained, and the above-mentioned absolute amount measuring method is used. In order to obtain two-dimensional information, it is assumed that the composition of the tissue of the subject is uniform, in addition to the problem that the device configuration and arithmetic processing are complicated. There is a problem that the measured value is not significant and accurate diagnosis is hindered.

【0004】そこで、二次元検出器で得られる二次元の
画像情報を用いて、測定時における有意な生体情報を得
る方法が提案されている。提案される一つの方法は、被
検体の二次元的な変化量を、測定波長及び測定時刻を異
ならせて測定した複数の画像データを取得し、この複数
波長、複数時刻の画像データを演算することによって、
測定時における有意な生体情報を得るものである。ま
た、提案される他の方法は、被検体を二次元検出器で検
出して得られる二次元の測定画像データと、被検体と独
立して得られる基準画像データとをそれぞれ複数の測定
波長で求め、この複数の測定波長による測定画像データ
と基準画像データとを用いて演算を行うことによって絶
対量を得るものである。
Therefore, a method of obtaining significant biological information at the time of measurement by using two-dimensional image information obtained by a two-dimensional detector has been proposed. One method proposed is to obtain a plurality of image data obtained by measuring a two-dimensional change amount of a subject with different measurement wavelengths and measurement times, and calculate the image data of the plurality of wavelengths and a plurality of times. By
This is to obtain significant biological information at the time of measurement. In addition, another method proposed is that two-dimensional measurement image data obtained by detecting a subject with a two-dimensional detector and reference image data obtained independently of the subject are respectively measured at a plurality of measurement wavelengths. The absolute amount is obtained by obtaining and calculating using the measurement image data and the reference image data by the plurality of measurement wavelengths.

【0005】[0005]

【発明が解決しようとする課題】従来提案されている、
二次元検出器で得られる二次元の画像情報を用いて測定
時における有意な生体情報を得る方法は、被検体中の成
分濃度と測定データとの間には直線比例関係があると仮
定し、この仮定に基づいた線形演算によって求めてい
る。
[Problems to be Solved by the Invention]
The method of obtaining significant biological information at the time of measurement using the two-dimensional image information obtained by the two-dimensional detector is assumed to have a linear proportional relationship between the component concentration in the subject and the measurement data, It is calculated by linear calculation based on this assumption.

【0006】しかしながら、被検体が生体の場合には、
生体中に強い散乱があるため、成分濃度と測定データ
(吸光度)との間には直線比例関係が成立するとは限ら
ず、特に、ヘモグロビン濃度(酸素化ヘモグロビン、脱
酸素化ヘモグロビン)やメラニン濃度の絶対量を計算し
た場合には、大きな誤差が生じるという問題がある。
However, when the subject is a living body,
Due to strong scattering in the living body, there is no guarantee that a linear proportional relationship is established between the component concentration and the measurement data (absorbance). In particular, hemoglobin concentration (oxygenated hemoglobin, deoxygenated hemoglobin) and melanin concentration When calculating the absolute amount, there is a problem that a large error occurs.

【0007】そこで、本発明は前記した従来の問題点を
解決し、被検体の成分濃度と測定データとの間の非直線
性を考慮して、より正確な成分濃度を求めることを目的
とし、さらに詳細には、生体中の散乱による吸光度とヘ
モグロビン濃度及びメラニン濃度との非線形性を考慮し
て、より正確なヘモグロビン濃度及びメラニン濃度を求
めることを目的とする。
Therefore, the present invention aims to solve the above-mentioned conventional problems and to obtain a more accurate component concentration in consideration of the non-linearity between the component concentration of the object and the measurement data. More specifically, it is an object of the present invention to obtain a more accurate hemoglobin concentration and melanin concentration in consideration of the nonlinearity between the absorbance due to scattering in the living body and the hemoglobin concentration and melanin concentration.

【0008】[0008]

【課題を解決するための手段】本発明は、生体中の組織
情報と測定データとの間の非線形関係を考慮し生体中の
組織情報を求めるものである。本発明は、生体に光を照
射し、生体から反射される光を二次元検出器を用いて画
像を得る光画像計測方法であり、生体中の組織情報と測
定データとの間の非線形関係を予め求めておき、この非
線形関係を用いて生体中の組織情報を求める。求める生
体中の組織情報として生体中の成分濃度とすることがで
きる。
The present invention seeks tissue information in a living body in consideration of a non-linear relationship between tissue information in the living body and measurement data. The present invention is an optical image measurement method of irradiating a living body with light and obtaining an image of light reflected from the living body by using a two-dimensional detector, and shows a non-linear relationship between tissue information in the living body and measurement data. Obtained in advance, the tissue information in the living body is obtained using this non-linear relationship. As the tissue information in the living body to be obtained, the component concentration in the living body can be used.

【0009】本発明は二つの態様を含み、第一の態様に
よれば生体中の成分濃度を求めることができ、第二の態
様によれば生体中の成分濃度変化を求めることができ
る。第一の態様は生体中の成分濃度を求めるものであ
り、二つの形態とすることができる。生体中の成分濃度
を求める第一の形態は、生体中の成分濃度と測定データ
との非線形関係を予め関係式によって求めておき、複数
の測定波長による測定画像データをこの関係式にフィッ
ティングさせることによって、生体中の成分濃度を求め
る。また、生体中の成分濃度を求める第二の形態は、生
体中の成分濃度と測定データとの非線形関係を予め参照
テーブルによって求めておき、複数の測定波長による測
定画像データをこの参照テーブルに照合させることによ
って、生体中の成分濃度を求める。
The present invention includes two aspects. According to the first aspect, it is possible to obtain the component concentration in the living body, and according to the second aspect, it is possible to obtain the change in the component concentration in the living body. The first mode is to obtain the concentration of a component in a living body, which can be in two forms. The first form of obtaining the component concentration in the living body is to obtain the non-linear relationship between the component concentration in the living body and the measurement data by a relational expression in advance, and fit the measurement image data at a plurality of measurement wavelengths to this relational expression. Then, the concentration of the component in the living body is obtained. In the second embodiment for obtaining the concentration of components in the living body, the non-linear relationship between the concentration of components in the living body and the measurement data is obtained in advance by a reference table, and the measurement image data at a plurality of measurement wavelengths is collated with this reference table. By doing so, the concentration of the component in the living body is obtained.

【0010】また、第二の態様は生体中の成分濃度変化
を求めるものであり、測定画像データの変化を生体中の
成分濃度変化と各成分による拡散によって生体中を光が
飛行する距離である平均光路長との積を含む関係式によ
って表しておき、この関係式に少なくとも測定する成分
と同数の複数の測定波長による測定画像データを適用す
ることによって、生体中の成分濃度変化を求める。
The second mode is to obtain the change in the concentration of the component in the living body, and the change in the measurement image data is the change in the concentration of the component in the living body and the distance that light travels in the living body due to diffusion by each component. It is represented by a relational expression including the product of the average optical path length, and the measurement image data at a plurality of measurement wavelengths of at least the same number as the component to be measured is applied to this relational expression to obtain the change in the concentration of the component in the living body.

【0011】本発明の態様は、測定データとして吸光度
を用い、生体中の成分濃度として酸素化ヘモグロビン濃
度、脱酸素化ヘモグロビン濃度、メラニン濃度を求め
る。また、生体中の成分濃度と測定データとの間の非線
形関係は、生体をメラニンを含む層(表皮)、酸素化ヘ
モグロビン及び脱酸素化ヘモグロビンを含む層(真
皮)、脂肪を含む層(脂肪層)の3層モデルを用い、こ
の3層モデルに対してモンテカルロシミュレーションを
適応して求める。第二の態様の関係式は、ランベルト−
ベールの法則に、モンテカルロシミュレーションで求め
た各成分の拡散による光の平均飛行距離を適用すること
で求める。
In the embodiment of the present invention, the absorbance is used as the measurement data, and the oxygenated hemoglobin concentration, the deoxygenated hemoglobin concentration, and the melanin concentration are obtained as the component concentrations in the living body. In addition, the nonlinear relationship between the concentration of components in the living body and the measurement data is that the living body is a layer containing melanin (epidermis), a layer containing oxygenated hemoglobin and deoxygenated hemoglobin (dermis), a layer containing fat (fat layer). ) Is used, and Monte Carlo simulation is applied to the three-layer model to obtain the model. The relational expression of the second aspect is Lambert-
It is obtained by applying the average flight distance of light due to diffusion of each component obtained by Monte Carlo simulation to Beer's law.

【0012】[0012]

【発明の実施の形態】以下、本発明の実施の形態を、図
を参照しながら詳細に説明する。以下、本発明の光画像
計測方法が測定する生体の組織情報として生体中の成分
濃度あるいは成分濃度変化、特に、酸素化ヘモグロビ
ン、脱酸素化ヘモグロビン、メラニンの場合について説
明する。
BEST MODE FOR CARRYING OUT THE INVENTION Embodiments of the present invention will be described in detail below with reference to the drawings. Hereinafter, as the tissue information of the living body measured by the optical image measuring method of the present invention, the component concentration or the change in the component concentration in the living body, particularly the case of oxygenated hemoglobin, deoxygenated hemoglobin, and melanin will be described.

【0013】本発明は、生体に光を照射し、生体から反
射される光を二次元検出器を用いて得た画像データを用
いて光画像計測を行うものであり、光源から生体に対し
て複数の波長の光を照射し、生体から反射される光を二
次元検出器で検出して測定データを得、この測定データ
をデータ処理することによって、酸素化ヘモグロビン、
脱酸素化ヘモグロビン、メラニン等の生体中の成分濃度
あるいは成分濃度変化を求める。
The present invention is to irradiate a living body with light and perform optical image measurement of light reflected from the living body using image data obtained by using a two-dimensional detector. By irradiating light with a plurality of wavelengths, the light reflected from the living body is detected by a two-dimensional detector to obtain measurement data, and by processing the measurement data, oxygenated hemoglobin,
The concentration of components such as deoxygenated hemoglobin and melanin in the living body or the change in the concentration of components is obtained.

【0014】本発明の光画像計測方法では、このデータ
処理において、予め求めておいた、生体中の成分濃度と
測定データとの間の非線形関係を用いることによって、
非線形性による影響を排除した生体中の成分濃度あるい
は成分濃度変化を求める。本発明の光画像計測方法は二
つの態様を含み、第一の態様によれば生体中の成分濃度
を求めることができ、第二の態様によれば生体中の成分
濃度変化を求めることができる。何れの態様も、生体中
の成分濃度と測定データとの間の非線形関係を予め求め
ておき、この非線形関係に基づいて測定データのデータ
処理を行う。
In the optical image measuring method of the present invention, in this data processing, by using the non-linear relationship between the concentration of the constituent in the living body and the measurement data, which is obtained in advance,
The component concentration in the living body or the change in the component concentration without the influence of non-linearity is obtained. The optical image measuring method of the present invention includes two aspects. According to the first aspect, it is possible to obtain the component concentration in the living body, and according to the second aspect, it is possible to obtain the change in the component concentration in the living body. . In any of the embodiments, a non-linear relationship between the component concentration in the living body and the measurement data is obtained in advance, and data processing of the measurement data is performed based on this non-linear relationship.

【0015】はじめに、生体中の成分濃度と測定データ
との間の非線形関係を求める一例について説明する。こ
こでは、生体の皮膚組織を表皮、真皮、脂肪層からなる
3層モデルを仮定し、このモデルに対してモンテカルロ
シミュレーションの手法を適用する。
First, an example of obtaining a non-linear relationship between the concentration of a component in the living body and the measurement data will be described. Here, a three-layer model including the epidermis, dermis, and fat layer is assumed for the skin tissue of the living body, and the Monte Carlo simulation method is applied to this model.

【0016】図1は、生体の皮膚組織1のモデル例であ
り、表面側から順に表皮2、真皮2、脂肪層3の3層の
モデルを仮定し、表皮2は厚さを0.06mmとしメラ
ニンが含まれ、真皮3は厚さを1.0mmとし酸素化ヘ
モグロビン(oxyHb)及び脱酸素化ヘモグロビン(deoxy
Hb)が含まれ、また、脂肪層は4厚さを28.94mm
とし脂肪が含まれると仮定する。
FIG. 1 is an example of a model of a skin tissue 1 of a living body, assuming a three-layer model of an epidermis 2, a dermis 2 and a fat layer 3 in order from the surface side, and the epidermis 2 has a thickness of 0.06 mm. It contains melanin, and the dermis 3 has a thickness of 1.0 mm and has oxygenated hemoglobin (oxyHb) and deoxygenated hemoglobin (deoxy).
Hb) is included, and the fat layer has a thickness of 28.94 mm.
And assume that it contains fat.

【0017】なお、ここで、真皮の層中の吸収係数μa
(mm−1)は、酸素化ヘモグロビン(oxyHb)の濃度
[oxyHb],脱酸素化ヘモグロビン(deoxyHb)の濃度
[deoxyHb],酸素化ヘモグロビン(oxyHb)のモル吸光
係数εoxyHb(mM−1・cm ),脱酸素化ヘモグ
ロビン(deoxyHb)のモル吸光係数εdeoxyHb(mM−1
・cm−1)を用いて、以下の式で表す係数を用いる。
Here, the absorption coefficient μa in the dermis layer
(Mm −1 ) is the concentration [oxyHb] of oxygenated hemoglobin (oxyHb), the concentration [deoxyHb] of deoxygenated hemoglobin (deoxyHb), the molar extinction coefficient ε oxyHb (mM −1 · cm) of oxygenated hemoglobin (oxyHb). - 1), the molar extinction coefficient of deoxygenated hemoglobin (deoxyHb) ε deoxyHb (mM -1
-Cm <-1> is used and the coefficient represented by the following formula is used.

【0018】 μ=ln10・(εoxyHb・[oxyHb]+εdeoxyHb・[deoxyHb])/10 …(1) このモデルに対して、各波長毎にモンテカルロシミュレ
ーションの手法を適用し、任意の時間の光量Iのリフ
ァレンス光をモデル内で擬似的に発生させ、この光がモ
デル内で散乱して生体から放出される反射光の光量Iを
求める。このモンテカルロシミュレーションの適用によ
って得られた光量I及び光量Iを用いることによっ
て、吸光度に対応する値(abs=−log(I/I))を
求めることができる。このモデルに対するモンテカルロ
シミュレーションの適用によって得られた値は、生体中
の成分濃度と測定データとの間の非線形関係を含むた
め、この値から逆に生体中の成分濃度と測定データとの
間の非線形関係を知ることができる。
Μ a = ln10 · (ε oxyHb · [oxyHb] + ε deoxyHb · [deoxyHb]) / 10 (1) The Monte Carlo simulation method is applied to this model for each wavelength, and The reference light of the light quantity I 0 is generated pseudo in the model, and the light quantity I of the reflected light emitted from the living body by scattering this light in the model is obtained. By using the light amount I 0 and the light amount I obtained by applying the Monte Carlo simulation, the value (abs = −log (I / I 0 )) corresponding to the absorbance can be obtained. Since the value obtained by applying the Monte Carlo simulation to this model includes the nonlinear relationship between the concentration of the constituent in the living body and the measured data, the nonlinearity between the concentration of the constituent in the living body and the measured data is reversed from this value. You can know the relationship.

【0019】前記したモデルに対してモンテカルロシミ
ュレーションを適用して得られる光量I及び光量Iを
用いて測定データに対応する吸光度(Z=−log(I/
))を複数求め、これらの複数の吸光度と各成分濃
度との関係をプロットすることによって、成分濃度と測
定データとの間の非線形関係を表すことができる。この
非線形関係は、例えばグラフや関係式によって表すこと
ができる。
Using the light quantity I 0 and the light quantity I obtained by applying Monte Carlo simulation to the above model, the absorbance (Z = −log (I /
By obtaining a plurality of I 0 )) and plotting the relationship between the plurality of absorbances and the concentration of each component, a non-linear relationship between the component concentration and the measurement data can be expressed. This non-linear relationship can be represented by, for example, a graph or a relational expression.

【0020】図2は、成分濃度と測定データとの間の非
線形関係を表すグラフ表示例である。なお、図2は測定
波長が581nmの例を示している。このグラフ表示で
は、モンテカルロシミュレーションで求めた吸光度をZ
軸に表すと共に、前記式(1)で表される各波長におけ
る真皮中のヘモグロビン吸収係数μ(mm−1)をX
軸に表し、表皮のメラニン濃度(mg/ml)をY軸に
表している。なお、この成分濃度と測定データとの間の
非線形関係は各波長毎に得られる。
FIG. 2 is a graph display example showing a non-linear relationship between component concentrations and measured data. Note that FIG. 2 shows an example in which the measurement wavelength is 581 nm. In this graph display, the absorbance obtained by Monte Carlo simulation is Z
Along the axis, the hemoglobin absorption coefficient μ a (mm −1 ) in the dermis at each wavelength represented by the formula (1) is represented by X.
It is shown on the axis, and the epidermal melanin concentration (mg / ml) is shown on the Y axis. The nonlinear relationship between the component concentration and the measurement data is obtained for each wavelength.

【0021】また、成分濃度と測定データとの間の非線
形関係を関係式で表すと、以下の式で表すことができ
る。
The non-linear relationship between the component concentration and the measured data can be expressed by the following expression.

【0022】 Z=AZ+BXY+CXY+DY+EX +FXY+GY+HX+IY+J …(2) ここで、Xは真皮中のヘモグロビン吸収係数μ(mm
−1)であり、Yは表皮のメラニン濃度(mg/ml)
である。また、係数AからJは波長毎に異なる定数であ
り、係数Jは全波長に共通するオフセット値である。表
1は、測定波長をそれぞれ512nm、557nm、5
68nm、581nm、619nm、700nmの場合
としたときに得られる式(2)の各係数A〜Jを示して
いる。
Z = AZ 3 + BX 2 Y + CXY 2 + DY 3 + EX 2 + FXY + GY 2 + HX + IY + J (2) Here, X is the hemoglobin absorption coefficient μ a (mm) in the dermis.
-1 ), and Y is the epidermal melanin concentration (mg / ml)
Is. Further, the coefficients A to J are constants that differ for each wavelength, and the coefficient J is an offset value common to all wavelengths. Table 1 shows the measurement wavelengths of 512 nm, 557 nm and 5 nm, respectively.
The respective coefficients A to J of the equation (2) obtained in the case of 68 nm, 581 nm, 619 nm, and 700 nm are shown.

【0023】[0023]

【表1】 [Table 1]

【0024】本発明の光画像計測方法は、上記成分濃度
と測定データとの間の非線形関係に基づいて、生体中の
成分濃度あるいは成分濃度変化を求める。はじめに、成
分濃度と測定データとの間の非線形関係を用いて、生体
中の成分濃度を求める第一の態様について説明する。
According to the optical image measuring method of the present invention, the component concentration in the living body or the component concentration change is obtained based on the non-linear relationship between the component concentration and the measurement data. First, the first mode for obtaining the component concentration in the living body by using the non-linear relationship between the component concentration and the measurement data will be described.

【0025】第一の態様では、複数の測定波長による測
定画像データを前記関係式(2)にフィッティングさせ
たり、あるいは、生体中の成分濃度と測定データとの非
線形関係を予め参照テーブルによって求めておき、複数
の測定波長による測定画像データをこの参照テーブルに
照合させることによって、生体中の成分濃度を求める。
参照テーブルは、例えば図1に示すグラフの形態とする
ことができる。以下、測定画像データを関係式(2)に
フィッティングさせることによって生体中の成分濃度を
求める場合を説明する。
In the first aspect, the measurement image data at a plurality of measurement wavelengths is fitted to the above relational expression (2), or the non-linear relationship between the concentration of components in the living body and the measurement data is obtained in advance by a look-up table. Then, the concentration of the component in the living body is obtained by collating the measurement image data of a plurality of measurement wavelengths with this reference table.
The lookup table can be in the form of the graph shown in FIG. 1, for example. Hereinafter, a case will be described where the measured image data is fitted to the relational expression (2) to obtain the component concentration in the living body.

【0026】このフィッティングによる場合には、生体
について少なくとも2波長による測定データから実測し
た吸光度absを求めると共に、同じ2波長のシミュレー
ション結果から吸光度Zを求め、この実測吸光度absと
シミュレーションによる吸光度Zとの差Sが最小となる
ような、ヘモグロビン吸収係数X(=μ)(m
)とメラニン濃度Y(mg/ml)を決定し、こ
れからメラニン濃度及びヘモグロビン濃度を求める。な
お、実測吸光度absとシミュレーションによる吸光度Z
との差Sは、以下の式(3)で表し、使用する波長数n
についてこの差Sを最小とするX,Yを求める。
In the case of this fitting, the absorbance abs actually measured from the measurement data of at least two wavelengths of the living body is obtained, the absorbance Z is obtained from the simulation result of the same two wavelengths, and the actually measured absorbance abs and the absorbance Z by the simulation are obtained. The hemoglobin absorption coefficient X (= μ a ) (m
m - 1 ) and the melanin concentration Y (mg / ml) are determined, and the melanin concentration and hemoglobin concentration are calculated from this. The measured absorbance abs and the simulated absorbance Z
The difference S between and is expressed by the following equation (3), and the number of wavelengths to be used n
X, Y that minimizes the difference S is obtained.

【0027】[0027]

【数1】 [Equation 1]

【0028】また、図1に示すグラフに示されるヘモグ
ロビン吸収係数μaとメラニン濃度と吸光度Zをテーブ
ルとして用意し、複数波長の実測した吸光度absとテー
ブルに備えるシミュレーション結果の吸光度値Zとの間
の差Sが最も小さくなるX,Yを決定し、メラニン濃度
及びヘモグロビン濃度を求めることもできる。表2は、
実測した測定データに対するフィッティングの結果例で
ある。
Further, the hemoglobin absorption coefficient μa, the melanin concentration and the absorbance Z shown in the graph shown in FIG. 1 are prepared as a table, and between the measured absorbances abs of a plurality of wavelengths and the absorbance value Z of the simulation result provided in the table. The melanin concentration and the hemoglobin concentration can be obtained by determining X and Y that minimize the difference S. Table 2 shows
It is an example of the result of fitting with respect to the measured data actually measured.

【0029】[0029]

【表2】 [Table 2]

【0030】なお、表2において、例1から例4は同一
人における、安静時、加熱時、圧迫時、及び開放時の各
状態を示し、例5は別人の状態を示し、それぞれ、関係
式(1)の変数である、酸素化ヘモグロビン濃度[oxyH
b](μM),脱酸素化ヘモグロビン濃度[deoxyHb]
(μM),メラニン濃度[melanin](mg/ml),
オフセット値の他、酸素化ヘモグロビン濃度[oxyHb]
と脱酸素化ヘモグロビン濃度[deoxyHb]の和のヘモグ
ロビン濃度[totalHb],酸素飽和度SO(100[o
xyHb]/[totalHb]),及びフィッティング後の吸光
度の最大残余を示している。
In Table 2, Examples 1 to 4 show the respective states of the same person at rest, during heating, under pressure, and during release, and Example 5 shows the state of another person, each of which has a relational expression. Oxygenated hemoglobin concentration [oxyH] which is a variable of (1)
b] (μM), deoxygenated hemoglobin concentration [deoxyHb]
(ΜM), melanin concentration [melanin] (mg / ml),
In addition to offset value, oxygenated hemoglobin concentration [oxyHb]
And deoxygenated hemoglobin concentration [deoxyHb], the total hemoglobin concentration [totalHb], oxygen saturation SO 2 (100 [o
xyHb] / [totalHb]) and the maximum residual absorbance after fitting.

【0031】次に、成分濃度変化と測定データ変化との
間の非線形関係を用いて、生体中の成分濃度変化を求め
る第二の態様について説明する。第二の態様では、生体
中の成分濃度変化と各成分による拡散によって生体中を
光が飛行する平均光路長との積を含む関係式によって、
測定画像データの変化を表しておき、この関係式に少な
くとも測定する成分と同数の複数の測定波長による測定
画像データを適用することによって、生体中の成分濃度
変化を求める。
Next, a second mode for obtaining the component concentration change in the living body by using the non-linear relationship between the component concentration change and the measurement data change will be described. In the second aspect, by a relational expression including a product of a change in the concentration of a component in a living body and an average optical path length in which light flies in the living body due to diffusion by each component,
The change in the measurement image data is expressed in advance, and the change in the concentration of the component in the living body is obtained by applying to this relational expression the measurement image data at a plurality of measurement wavelengths at least as many as the components to be measured.

【0032】第二の態様の関係式は、ランベルト−ベー
ルの法則に、モンテカルロシミュレーションで求めた各
成分の拡散による光の平均光路長を適用することで求め
ることができる。
The relational expression of the second aspect can be obtained by applying the average optical path length of light due to diffusion of each component obtained by Monte Carlo simulation to the Lambert-Beer law.

【0033】ランベルト−ベールの法則に、拡散による
光の平均光路長dを適用すると、以下の式(4)で表さ
れる。 ΔZ=doxyHb・εoxyHb・Δ[oxyHb]+ddeoxyHb・εdeoxyHb・Δ[deoxyHb] +dmelanin・εmelanin・Δ[melanin]+ΔJ …(4) ここで、ΔZは酸素化ヘモグロビン濃度の変化Δ[oxyH
b],脱酸素化ヘモグロビン濃度の変化Δ[deoxyHb],
及びメラニン濃度の変化Δ[melanin]による吸光度の
変化であり、doxyHb,ddeoxyHb,dmelaninはそれぞ
れ酸素化ヘモグロビン,脱酸素化ヘモグロビン,及びメ
ラニンの拡散による光の平均光路長である。
When the average optical path length d of light due to diffusion is applied to the Lambert-Beer law, it is expressed by the following equation (4). ΔZ = d oxyHb · ε oxyHb · Δ [oxyHb] + d deoxyHb · ε deoxyHb · Δ [deoxyHb] + d melanin · ε melanin · Δ [melanin] + ΔJ (4) where ΔZ is the change in oxygenated hemoglobin concentration Δ [ oxyH
b], change in deoxygenated hemoglobin concentration Δ [deoxyHb],
And the change in absorbance due to changes delta [melanin] melanin concentration, d oxyHb, d deoxyHb, d melanin is the mean path length of light by the diffusion of the respective oxygenated hemoglobin, deoxygenated hemoglobin, and melanin.

【0034】ここで、式(2)において、吸光度Zは酸
素化ヘモグロビン濃度[oxyHb],脱酸素化ヘモグロビ
ン濃度[deoxyHb],メラニン濃度[melanin],及び定
数Jの関数であるので、ΔZは以下の式(5)で一次近
似することができる。
In formula (2), the absorbance Z is a function of oxygenated hemoglobin concentration [oxyHb], deoxygenated hemoglobin concentration [deoxyHb], melanin concentration [melanin], and constant J, so ΔZ is The first-order approximation can be performed by the equation (5).

【0035】 ΔZ=(∂Z/∂[oxyHb])・Δ[oxyHb] +(∂Z/∂[deoxyHb])・Δ[deoxyHb] +(∂Z/∂[melanin])・Δ[melanin]+ΔJ …(5) この式(5)と式(1)を対比により、以下の式
(6),(7),(8)で表される関係が得られる。
ΔZ = (∂Z / ∂ [oxyHb]) ・ Δ [oxyHb] + (∂Z / ∂ [deoxyHb]) ・ Δ [deoxyHb] + (∂Z / ∂ [melanin]) ・ Δ [melanin] + ΔJ (5) By comparing the equation (5) with the equation (1), the relationships represented by the following equations (6), (7), and (8) are obtained.

【0036】 (∂Z/∂[oxyHb]) =(∂Z/∂X)・(∂X/∂[oxyHb]) =(∂Z/∂X)・(ln10/10)・doxyHb …(6) (∂Z/∂[deoxyHb]) =(∂Z/∂X)・(∂X/∂[deoxyHb]) =(∂Z/∂X)・(ln10/10)・ddeoxyHb …(7) (∂Z/∂[melanin])=(∂Z/∂Y) …(8) 式(6),(7),(8)を用いて、式(4)と式
(5)を比較すると、各平均光路長は以下の式(9)で
表すことができる。
(∂Z / ∂ [oxyHb]) = (∂Z / ∂X) ・ (∂X / ∂ [oxyHb]) = (∂Z / ∂X) ・ (ln10 / 10) ・ d oxyHb (6) ) (∂Z / ∂ [deoxyHb]) = (∂Z / ∂X) ・ (∂X / ∂ [deoxyHb]) = (∂Z / ∂X) ・ (ln10 / 10) ・ d deoxyHb … (7) (7) ∂Z / ∂ [melanin]) = (∂Z / ∂Y) (8) Using formulas (6), (7), and (8), comparing formula (4) and formula (5), The average optical path length can be expressed by the following equation (9).

【0037】 doxyHb=(∂Z/∂X)・(ln10/10), ddeoxyHb=(∂Z/∂X)・(ln10/10), dmelanin=(∂Z/∂Y)・(1/εmelanin ) …(9) 式(9)中の(∂Z/∂X),(∂Z/∂Y)は、式
(2)から以下の式(10),(1)で表される。
D oxyHb = (∂Z / ∂X) · (ln10 / 10), d deoxyHb = (∂Z / ∂X) · (ln10 / 10), d melanin = (∂Z / ∂Y) · (1 / Ε melanin ) (9) (∂Z / ∂X) and (∂Z / ∂Y) in the formula (9) are expressed by the following formulas (10) and (1) from the formula (2). .

【0038】 ∂Z/∂X=3AX+2BXY+CY+2EX+FY+H …(10) ∂Z/∂Y=BX+2CXY+3DY+FX+2GY+I …(11) 式(10),(11)の(∂Z/∂X),(∂Z/∂
Y)を定めるには、各測定例においてX,Yの値を特定
する必要がある。そこで、前記表2の例1と例5につい
て平均光路長を求めると、表3及び表4で表される値が
得られる。なお、表3は例1による値であり、表4は例
2による値である。
[0038] ∂Z / ∂X = 3AX 2 + 2BXY + CY 2 + 2EX + FY + H ... (10) ∂Z / ∂Y = BX 2 + 2CXY + 3DY 2 + FX + 2GY + I ... (11) (10), of (11) (∂Z / ∂X) , (∂Z / ∂
To determine Y), it is necessary to specify X and Y values in each measurement example. Then, when the average optical path lengths are obtained for the examples 1 and 5 of the above Table 2, the values shown in Tables 3 and 4 are obtained. Table 3 shows the values according to Example 1, and Table 4 shows the values according to Example 2.

【0039】[0039]

【表3】 [Table 3]

【0040】[0040]

【表4】 [Table 4]

【0041】ここで、式(4)に表3で表される平均光
路長を適用すると各波長における吸光度変化ΔZは式
(12)で表される。
When the average optical path length shown in Table 3 is applied to the equation (4), the absorbance change ΔZ at each wavelength is represented by the equation (12).

【0042】[0042]

【数2】 [Equation 2]

【0043】この式(12)から、酸素化ヘモグロビン
濃度変化Δ[oxyHb],脱酸素化ヘモグロビン濃度変化
Δ[deoxyHb],メラニン濃度変化Δ[melanin],及び
定数変化ΔJは各式(13)で解くことができる。
From this equation (12), the oxygenated hemoglobin concentration change Δ [oxyHb], the deoxygenated hemoglobin concentration change Δ [deoxyHb], the melanin concentration change Δ [melanin], and the constant change ΔJ are expressed by the respective equations (13). Can be solved.

【0044】[0044]

【数3】 [Equation 3]

【0045】また、例5についても同様に解くことによ
って、前記式(12),(13)に対応する式(1
4),(15)が得られる。
Similarly, by solving for Example 5 as well, the equation (1) corresponding to the equations (12) and (13) is obtained.
4) and (15) are obtained.

【0046】[0046]

【数4】 [Equation 4]

【0047】[0047]

【数5】 [Equation 5]

【0048】本発明の光画像計測方法は、上記した第1
の態様で求める生体中の成分濃度、及び第2の態様で求
める生体中の成分濃度変化を、例えば各画素毎に求める
ことによって画像データを得ることができ、二次元画像
によって表示することができる。
The optical image measuring method of the present invention comprises the above-mentioned first method.
The image data can be obtained by, for example, obtaining the component concentration in the living body obtained in the above aspect and the change in the component concentration in the living body obtained in the second aspect for each pixel, and the image data can be displayed as a two-dimensional image. .

【0049】[0049]

【発明の効果】以上説明したように、本発明の光画像計
測方法によれば、被検体の成分濃度と測定データとの間
の非直線性を考慮して、より正確な成分濃度を求めるこ
とができる。また、生体中の散乱による吸光度とヘモグ
ロビン濃度及びメラニン濃度との非線形性を考慮して、
より正確なヘモグロビン濃度及びメラニン濃度を求める
ことができる。
As described above, according to the optical image measuring method of the present invention, a more accurate component concentration can be obtained in consideration of the non-linearity between the component concentration of the subject and the measurement data. You can Also, considering the non-linearity of the absorbance due to scattering in the living body and the hemoglobin concentration and melanin concentration,
More accurate hemoglobin concentration and melanin concentration can be obtained.

【図面の簡単な説明】[Brief description of drawings]

【図1】生体の皮膚組織のモデル例である。FIG. 1 is an example of a model of skin tissue of a living body.

【図2】本発明の光画像計測の成分濃度と測定データと
の間の非線形関係を表すグラフ表示例である。
FIG. 2 is a graph display example showing a non-linear relationship between a component concentration of optical image measurement of the present invention and measurement data.

【符号の説明】[Explanation of symbols]

1…生体組織、2…表皮、3…真皮、4…脂肪層。 1 ... Living tissue, 2 ... Epidermis, 3 ... Dermis, 4 ... Fat layer.

───────────────────────────────────────────────────── フロントページの続き (72)発明者 坂内 尚史 京都府京都市中京区西ノ京桑原町1番地 株式会社島津製作所内 Fターム(参考) 2G059 AA01 BB12 CC18 EE01 HH02 HH06 KK04 MM01 MM05 MM09 MM10 4C038 KK01 KL07 KX01    ─────────────────────────────────────────────────── ─── Continued front page    (72) Inventor Naofumi Sakauchi             1 Nishinokyo Kuwabaracho, Nakagyo Ward, Kyoto City, Kyoto Prefecture             Shimadzu Corporation F term (reference) 2G059 AA01 BB12 CC18 EE01 HH02                       HH06 KK04 MM01 MM05 MM09                       MM10                 4C038 KK01 KL07 KX01

Claims (5)

【特許請求の範囲】[Claims] 【請求項1】 生体に光を照射し、生体から反射される
光を二次元検出器を用いて画像を得る光画像計測方法に
おいて、複数の測定波長による測定画像データを、生体
中の成分濃度と測定データとの非線形関係を表す関係式
にフィッティングさせることによって、生体中の成分濃
度を求めることを特徴とする、光画像計測方法。
1. An optical image measuring method of irradiating a living body with light and obtaining an image of the light reflected from the living body by using a two-dimensional detector. The optical image measuring method is characterized in that the concentration of a component in a living body is obtained by fitting a relational expression representing a non-linear relation between the measurement data and the measurement data.
【請求項2】 生体に光を照射し、生体から反射される
光を二次元検出器を用いて画像を得る光画像計測方法に
おいて、複数の測定波長による測定画像データを、生体
中の成分濃度と測定データとの非線形関係を表す参照テ
ーブルに対照させることによって、生体中の成分濃度を
求めることを特徴とする、光画像計測方法。
2. An optical image measuring method of irradiating a living body with light and obtaining an image of the light reflected from the living body by using a two-dimensional detector, wherein measured image data at a plurality of measuring wavelengths is used as a component concentration in the living body. A method for measuring an optical image, characterized in that the concentration of a component in a living body is obtained by comparing a reference table showing a non-linear relationship between the measurement data and the measurement data.
【請求項3】 生体に光を照射し、生体から反射される
光を二次元検出器を用いて画像を得る光画像計測方法に
おいて、測定画像データの変化を、生体中の成分濃度変
化と各成分による拡散によって生体中を光が飛行する距
離である平均光路長との積を含む関係式で表し、少なく
とも測定する成分と同数の複数の測定波長による測定画
像データを、前記関係式に適用することによって、生体
中の成分濃度変化を求めることを特徴とする、光画像計
測方法。
3. An optical image measuring method for irradiating a living body with light and obtaining an image of the light reflected from the living body by using a two-dimensional detector. Expressed by a relational expression including a product with an average optical path length that is a distance that light travels in a living body due to diffusion by components, at least measurement image data with a plurality of measurement wavelengths of the same number as the component to be measured is applied to the relational expression. The optical image measuring method is characterized in that the change in the component concentration in the living body is obtained by the above.
【請求項4】 前記測定データは吸光度であり、前記生
体中の成分濃度は酸素化ヘモグロビン濃度、脱酸素化ヘ
モグロビン濃度、及びメラニン濃度であることを特徴と
する、請求項1乃至3の何れか一つに記載の光画像計測
方法。
4. The measurement data is absorbance, and the component concentrations in the living body are oxygenated hemoglobin concentration, deoxygenated hemoglobin concentration, and melanin concentration, according to any one of claims 1 to 3. The optical image measuring method described in one.
【請求項5】 前記非線形関係は、生体をメラニンを含
む層、酸素化ヘモグロビン及び脱酸素化ヘモグロビンを
含む層、脂肪層の3層モデルに対してモンテカルロシミ
ュレーションを適応して求めることを特徴とする、請求
項1乃至3の何れか一つに記載の光画像計測方法。
5. The non-linear relationship is obtained by applying a Monte Carlo simulation to a three-layer model of a layer containing melanin, a layer containing oxygenated hemoglobin and deoxygenated hemoglobin, and a fat layer in the living body. The optical image measuring method according to any one of claims 1 to 3.
JP2001347619A 2001-11-13 2001-11-13 Optical image measurement method Withdrawn JP2003149136A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2001347619A JP2003149136A (en) 2001-11-13 2001-11-13 Optical image measurement method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2001347619A JP2003149136A (en) 2001-11-13 2001-11-13 Optical image measurement method

Publications (1)

Publication Number Publication Date
JP2003149136A true JP2003149136A (en) 2003-05-21

Family

ID=19160596

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001347619A Withdrawn JP2003149136A (en) 2001-11-13 2001-11-13 Optical image measurement method

Country Status (1)

Country Link
JP (1) JP2003149136A (en)

Cited By (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011517416A (en) * 2008-03-18 2011-06-09 ボールター インク Optical methods for determining morphological parameters and physiological properties of tissues
JP2012231938A (en) * 2011-04-28 2012-11-29 Kao Corp Skin evaluation method and skin evaluation system
JP2013052182A (en) * 2011-09-06 2013-03-21 Kao Corp Method for measuring cutaneous pigment concentration
JP2015023953A (en) * 2013-07-25 2015-02-05 花王株式会社 Measurement method of concentration of pigment in skin
US9974475B2 (en) 2008-01-24 2018-05-22 Balter, Inc. Optical transfer diagnosis (OTD) method for discriminating between malignant and benign tissue lesions
US11168353B2 (en) 2011-02-18 2021-11-09 Bio-Rad Laboratories, Inc. Compositions and methods for molecular labeling
US11174509B2 (en) 2013-12-12 2021-11-16 Bio-Rad Laboratories, Inc. Distinguishing rare variations in a nucleic acid sequence from a sample
US11187702B2 (en) 2003-03-14 2021-11-30 Bio-Rad Laboratories, Inc. Enzyme quantification
US11224876B2 (en) 2007-04-19 2022-01-18 Brandeis University Manipulation of fluids, fluid components and reactions in microfluidic systems
US11254968B2 (en) 2010-02-12 2022-02-22 Bio-Rad Laboratories, Inc. Digital analyte analysis
US11351510B2 (en) 2006-05-11 2022-06-07 Bio-Rad Laboratories, Inc. Microfluidic devices
US11390917B2 (en) 2010-02-12 2022-07-19 Bio-Rad Laboratories, Inc. Digital analyte analysis
US11511242B2 (en) 2008-07-18 2022-11-29 Bio-Rad Laboratories, Inc. Droplet libraries
US11819849B2 (en) 2007-02-06 2023-11-21 Brandeis University Manipulation of fluids and reactions in microfluidic systems
US11898193B2 (en) 2011-07-20 2024-02-13 Bio-Rad Laboratories, Inc. Manipulating droplet size
US11901041B2 (en) 2013-10-04 2024-02-13 Bio-Rad Laboratories, Inc. Digital analysis of nucleic acid modification
US12038438B2 (en) 2008-07-18 2024-07-16 Bio-Rad Laboratories, Inc. Enzyme quantification
US12091710B2 (en) 2006-05-11 2024-09-17 Bio-Rad Laboratories, Inc. Systems and methods for handling microfluidic droplets
US12146134B2 (en) 2006-01-11 2024-11-19 Bio-Rad Laboratories, Inc. Microfluidic devices and methods of use in the formation and control of nanoreactors
US12352673B2 (en) 2009-03-23 2025-07-08 Bio-Rad Laboratories, Inc. Manipulation of microfluidic droplets

Cited By (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11187702B2 (en) 2003-03-14 2021-11-30 Bio-Rad Laboratories, Inc. Enzyme quantification
US12146134B2 (en) 2006-01-11 2024-11-19 Bio-Rad Laboratories, Inc. Microfluidic devices and methods of use in the formation and control of nanoreactors
US12337287B2 (en) 2006-05-11 2025-06-24 Bio-Rad Laboratories, Inc. Microfluidic devices
US12091710B2 (en) 2006-05-11 2024-09-17 Bio-Rad Laboratories, Inc. Systems and methods for handling microfluidic droplets
US11351510B2 (en) 2006-05-11 2022-06-07 Bio-Rad Laboratories, Inc. Microfluidic devices
US11819849B2 (en) 2007-02-06 2023-11-21 Brandeis University Manipulation of fluids and reactions in microfluidic systems
US11618024B2 (en) 2007-04-19 2023-04-04 President And Fellows Of Harvard College Manipulation of fluids, fluid components and reactions in microfluidic systems
US11224876B2 (en) 2007-04-19 2022-01-18 Brandeis University Manipulation of fluids, fluid components and reactions in microfluidic systems
US9974475B2 (en) 2008-01-24 2018-05-22 Balter, Inc. Optical transfer diagnosis (OTD) method for discriminating between malignant and benign tissue lesions
US9823189B2 (en) 2008-03-18 2017-11-21 Balter, As. Optical method for determining morphological parameters and physiological properties of tissue
JP2011517416A (en) * 2008-03-18 2011-06-09 ボールター インク Optical methods for determining morphological parameters and physiological properties of tissues
US11511242B2 (en) 2008-07-18 2022-11-29 Bio-Rad Laboratories, Inc. Droplet libraries
US11534727B2 (en) 2008-07-18 2022-12-27 Bio-Rad Laboratories, Inc. Droplet libraries
US11596908B2 (en) 2008-07-18 2023-03-07 Bio-Rad Laboratories, Inc. Droplet libraries
US12038438B2 (en) 2008-07-18 2024-07-16 Bio-Rad Laboratories, Inc. Enzyme quantification
US12352673B2 (en) 2009-03-23 2025-07-08 Bio-Rad Laboratories, Inc. Manipulation of microfluidic droplets
US12454718B2 (en) 2010-02-12 2025-10-28 Bio-Rad Laboratories, Inc. Digital analyte analysis
US11254968B2 (en) 2010-02-12 2022-02-22 Bio-Rad Laboratories, Inc. Digital analyte analysis
US11390917B2 (en) 2010-02-12 2022-07-19 Bio-Rad Laboratories, Inc. Digital analyte analysis
US11768198B2 (en) 2011-02-18 2023-09-26 Bio-Rad Laboratories, Inc. Compositions and methods for molecular labeling
US12140591B2 (en) 2011-02-18 2024-11-12 Bio-Rad Laboratories, Inc. Compositions and methods for molecular labeling
US12461094B2 (en) 2011-02-18 2025-11-04 Bio-Rad Laboratories, Inc. Compositions and methods for molecular labeling
US11168353B2 (en) 2011-02-18 2021-11-09 Bio-Rad Laboratories, Inc. Compositions and methods for molecular labeling
US11965877B2 (en) 2011-02-18 2024-04-23 Bio-Rad Laboratories, Inc. Compositions and methods for molecular labeling
US11747327B2 (en) 2011-02-18 2023-09-05 Bio-Rad Laboratories, Inc. Compositions and methods for molecular labeling
US12140590B2 (en) 2011-02-18 2024-11-12 Bio-Rad Laboratories, Inc. Compositions and methods for molecular labeling
JP2012231938A (en) * 2011-04-28 2012-11-29 Kao Corp Skin evaluation method and skin evaluation system
US11754499B2 (en) 2011-06-02 2023-09-12 Bio-Rad Laboratories, Inc. Enzyme quantification
US11898193B2 (en) 2011-07-20 2024-02-13 Bio-Rad Laboratories, Inc. Manipulating droplet size
JP2013052182A (en) * 2011-09-06 2013-03-21 Kao Corp Method for measuring cutaneous pigment concentration
JP2015023953A (en) * 2013-07-25 2015-02-05 花王株式会社 Measurement method of concentration of pigment in skin
US11901041B2 (en) 2013-10-04 2024-02-13 Bio-Rad Laboratories, Inc. Digital analysis of nucleic acid modification
US11174509B2 (en) 2013-12-12 2021-11-16 Bio-Rad Laboratories, Inc. Distinguishing rare variations in a nucleic acid sequence from a sample

Similar Documents

Publication Publication Date Title
JP2003149136A (en) Optical image measurement method
JP5186044B2 (en) Blood glucose level estimation device
Steinbrink et al. Determining changes in NIR absorption using a layered model of thehuman head
US6456862B2 (en) Method for non-invasive spectrophotometric blood oxygenation monitoring
JP3619969B2 (en) Light sensor with multiple light sources
Hallacoglu et al. Absolute measurement of cerebral optical coefficients, hemoglobin concentration and oxygen saturation in old and young adults with near-infrared spectroscopy
US20040122300A1 (en) Method for measuring venous oxygen saturation
US20040024297A1 (en) Method for spectrophotometric blood oxygenation monitoring
US9259486B2 (en) Method and system for calculating a quantification indicator for quantifying a dermal reaction on the skin of a living being
US20030023172A1 (en) Broadband absorption spectroscopy in turbid media by combined frequency-domain and steady state methodologies
US9339240B2 (en) System and method of resolving outliers in NIRS cerebral oximetry
Okui et al. Wavelength dependence of crosstalk in dual-wavelength measurement of oxy-and deoxy-hemoglobin
DK2689234T3 (en) PROCEDURE FOR DETERMINING THE ABSORPTION COEFFICIENT IN UNCLEAR MEDIUM
JPH09168531A (en) Method for quantitatively determining one or more characteristics of substance
US20120253149A1 (en) Method and apparatus for non-invasive photometric blood constituent diagnosis
JP2003144401A (en) Blood flow measurement device
Veesa et al. Functional near infrared spectroscopy using spatially resolved data to account for tissue scattering: A numerical study and arm‐cuff experiment
Jonasson et al. Absorption and reduced scattering coefficients in epidermis and dermis from a Swedish cohort study
Izzetoglu et al. Evaluation of cerebral tissue oximeters using multilayered dynamic head models
JP2010082246A (en) Method for processing measurement data of biological spectrum
Lee et al. Small separation frequency-domain near-infrared spectroscopy for the recovery of tissue optical properties at millimeter depths
Leung et al. Estimation of cerebral oxy-and deoxy-haemoglobin concentration changes in a layered adult head model using near-infrared spectroscopy and multivariate statistical analysis
JP3304559B2 (en) Optical measurement method and device
Sato et al. Extraction of depth-dependent signals from time-resolved reflectance in layered turbid media
US11583212B2 (en) Method and apparatus for non-invasive photometric blood constituent diagnosis

Legal Events

Date Code Title Description
A300 Withdrawal of application because of no request for examination

Free format text: JAPANESE INTERMEDIATE CODE: A300

Effective date: 20050201